Ashton Lavoie

Head of Downstream Process Development at BridgeBio Gene Therapy (BridgeBio Pharma)

Ashton is the Head of Downstream Process Development at BridgeBio Gene Therapy. She has been with BridgeBio for three years, with heavy focus on implementation of strategies and technologies to improve AAV purification processes. She earned her bachelors in Chemical Engineering at Northeastern University, and her masters and Ph.D. in Chemical Engineering at North Carolina State University. She has worked in biomanufacturing for 13 years with academic and industrial experience spanning upstream and downstream process development, technology transfer, and primary cell isolation.